| Literature DB >> 16298235 |
Katharina Buerger1, Markus Otto, Stefan J Teipel, Raymond Zinkowski, Kaj Blennow, John DeBernardis, Daniel Kerkman, Johannes Schröder, Peter Schönknecht, Lukas Cepek, Cheryl McCulloch, Hans-Jürgen Möller, Jens Wiltfang, Hans Kretzschmar, Harald Hampel.
Abstract
To study the potential diagnostic value of abnormally phosphorylated tau protein in Creutzfeldt-Jakob disease (CJD) compared to Alzheimer's disease (AD), we determined levels of tau phosphorylated at threonine 231 (p-tau231) and of total tau (t-tau) in cerebrospinal fluid (CSF) of CJD patients, AD patients, and healthy controls (HC). CJD patients showed excessively high t-tau levels but relatively low p-tau(231) concentrations compared to the AD group. t-tau alone yielded the best diagnostic accuracy to differentiate between CJD and AD patients, when compared to p-tau231 and the p-tau231/t-tau ratio (97, 78, and 95% correctly allocated cases, respectively). Our findings indicate a dissociation in the direction of change in CSF levels of t-tau and p-tau231 in CJD when compared to AD.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16298235 DOI: 10.1016/j.neurobiolaging.2004.12.003
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673